# Pylori Duo for Adjunctive Treatment and Prevention of Recurrence of Helicobacter Pylori Infection

> **NCT07729293** · NA · NOT_YET_RECRUITING · sponsor: **Gala Servicios Clinicos S.L.** · enrollment: 140 (estimated)

## Conditions studied

- Helicobacter Pylori Infection
- Dyspepsia
- Gastrointestinal Adverse Effects

## Interventions

- **DRUG:** Omeprazole
- **DRUG:** Pylera (Bismuth subcitrate potassium, metronidazole, tetracycline) given in combination with omeprazole
- **DIETARY_SUPPLEMENT:** Pylori Duo
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07729293
- **Lead sponsor:** Gala Servicios Clinicos S.L.
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-31
- **Primary completion:** 2027-10-07
- **Final completion:** 2028-09-30
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2026-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07729293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07729293, "Pylori Duo for Adjunctive Treatment and Prevention of Recurrence of Helicobacter Pylori Infection". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07729293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*